Jump to ContentJump to Main Navigation
Medicines management for nursing practicePharmacology, patient safety, and procedures$
Users without a subscription are not able to see the full content.

Graham Brack, Penny Franklin, and Jill Caldwell

Print publication date: 2013

Print ISBN-13: 9780199697878

Published to Oxford Scholarship Online: November 2020

DOI: 10.1093/oso/9780199697878.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 21 October 2021

Groups at Special Risk of Adverse Effects

Groups at Special Risk of Adverse Effects

Chapter 5 (p.82) Groups at Special Risk of Adverse Effects
Medicines management for nursing practice

Graham Brack

Penny Franklin

Jill Caldwell

Oxford University Press

In Chapters 3 and 4 the general principles of pharmacokinetics and pharmacodynamics were addressed. This chapter builds on these principles and looks at specific groups and situations. After reading this chapter you should be able to:… ● Identify groups of patients at extra risk of interactions, explain why, and relate this to nursing practice. ● Identify groups of patients at more risk of adverse events from medications, explain why, and relate this to nursing practice. ● Understand why some patients might be at higher risk and how this might be managed…. This chapter will look at a range of patients from the perspective of the nurse administering medicines. Whilst care must be taken when administering medication to any patient, there are groups of patients where the risk of problems occurring as a result of having to take medication are higher and it is therefore even more important to be vigilant. For some patients the treatment will have to be altered to reduce risk. While this is not the responsibility of the student nurse it is their responsibility to be vigilant to changes in the patient and to report this to trained staff. There are some circumstances in which the risk to patients is always higher because the treatment they are receiving carries more risk. For example, patients undergoing cancer chemotherapy are receiving drugs which tend to be highly toxic. While the risk of some degree of harm is high, this is justified by the great benefit that patients can derive. However, it is vital that every effort is made to reduce risk. Similarly there are features of care in acute settings such as operating theatres and intensive care units that could increase the risk to patients (Neale et al, 2001 ). Staff may be under acute pressure, so it becomes harder to follow all the steps in a routine.

Keywords:   E numbers, branded drugs, children, generic drugs, liver impairment, older patients, polypharmacy, renal impairment, teratogenicity

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .